Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker

Schmohl, Joerg U.; Felices, Martin; Taras, Elizabeth; Miller, Jeff S.; Vallera, Daniel A.

dc.contributor.author	Schmohl, Jörg Uwe
dc.date.accessioned	2019-01-22T10:16:59Z
dc.date.available	2019-01-22T10:16:59Z
dc.date.issued	2016
dc.identifier.issn	1525-0024
dc.identifier.uri	http://hdl.handle.net/10900/85855
dc.language.iso	en	de_DE
dc.publisher	Cell Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/mt.2016.88	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_02078
utue.publikation.seiten	1312-1322	de_DE
utue.personen.roh	Schmohl, Joerg U.
utue.personen.roh	Felices, Martin
utue.personen.roh	Taras, Elizabeth
utue.personen.roh	Miller, Jeff S.
utue.personen.roh	Vallera, Daniel A.
dcterms.isPartOf.ZSTitelID	Molecular Therapy	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE